StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Medrol [legacy through FY23] by Year

Medrol (methylprednisolone) [legacy through FY23] — International operational (constant-currency) YoY (%) (%)

QuarterlyAnnual

Pfizer Medrol [legacy through FY23]: 3.0% in FY2023, up 33.0 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2023
3.0%
Period ended Dec 31, 2023
Change on a year earlier
+33.0 pts
-30.0% in FY2022
History
7 years
Since FY2017
Sources
7
Documents cited below

Where the FY2023 figure comes from

“|| Medrol | 61 | 56 | 9% | 7% | 39 | 36 | 8% | 14% | 106 | 103 | 3% | 5%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedrol (methylprednisolone) [legacy through FY23] — International operational (constant-currency) YoY (%) (%)Year on yearSource
FY2023Dec 31, 20233.0%+33.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2022Dec 31, 2022-30.0%-65.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2021Dec 31, 202135.0%+37.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312021xex99.htm, filed 2022-02-08) ↗
FY2020Dec 31, 2020-2.0%+10.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312020xex99.htm, filed 2021-02-02) ↗
FY2019Dec 31, 2019-12.0%-8.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312019xex99.htm, filed 2020-01-28) ↗
FY2018Dec 31, 2018-4.0%-5.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312018xex99.htm, filed 2019-01-29) ↗
FY2017Dec 31, 20171.0%–Form 8-K (Earnings / Guidance Release) (pfe-12312017xex99.htm, filed 2018-01-30) ↗

Cite this data

StockData. (2026). Pfizer Medrol [legacy through FY23] (%), annual FY2017–FY2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/medrol-leg-oper-intl

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.